SCHEMBL17876202

SCHEMBL17876202

CC1(C)Oc2ccc(-c3ccc4oc5ccccc5c4c3)cc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
ALOX5 P09917 2/20 0.39
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PGR P06401 1/20 0.36
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
PLA2G2A P14555 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876147 0.95 HSP90AA1 (0.36) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876142 0.95 HSP90AA1 (0.36) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876207 0.95 ALOX5 (0.42) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876199 0.93 ALOX5 (0.39) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876204 0.91 MAPT (0.44) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876208 0.90 PLA2G2A (0.38) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876149 0.90 ALOX5 (0.39) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876190 0.89 ALOX5 (0.52) HSP90AA1HSP90AB1ALOX5MAPTMEN1
SCHEMBL17876191 0.89 ALOX5 (0.52) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17876136 0.88 ALOX5 (0.36) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 HSP90AA1 4363/4885HSP90AB1 4642/4885ALOX5 3059/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 HSP90AA1 4363/4885HSP90AB1 4642/4885ALOX5 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.